1071811-73-8 Usage
Uses
Used in Pharmaceutical Industry:
6-Methoxy-2-Methyl-1H-pyrrolo[2,3-b]pyridine is used as a potential anticancer agent for its inhibitory effects on cancer cell growth. It has been studied for its potential to target and reduce the proliferation of cancer cells, making it a promising candidate for further research and development in oncology.
Used in Neurological Applications:
6-Methoxy-2-Methyl-1H-pyrrolo[2,3-b]pyridine is used as a potential treatment for neurological disorders due to its ability to modulate neurotransmitter receptors. Its interaction with these receptors suggests that it may have therapeutic potential in the management of various neurological conditions, warranting further investigation in this field.
Used in Medicinal Chemistry Research:
6-Methoxy-2-Methyl-1H-pyrrolo[2,3-b]pyridine is used as a subject of study in medicinal chemistry for its diverse biological activities and potential therapeutic applications. Researchers are interested in understanding its mechanisms of action and exploring its potential as a lead compound in the development of new drugs for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1071811-73-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,1,8,1 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1071811-73:
(9*1)+(8*0)+(7*7)+(6*1)+(5*8)+(4*1)+(3*1)+(2*7)+(1*3)=128
128 % 10 = 8
So 1071811-73-8 is a valid CAS Registry Number.
1071811-73-8Relevant articles and documents
ANTIDIABETIC AZAINDOLES AND DIAZAINDOLES
-
Page/Page column 66-67, (2009/03/07)
Azaindoles and diazaindoles having aromatic substituents on the 5-membered ring are agonists or partial agonists of the PPAR receptor and are useful in the treatment and control of type 2 diabetes and of symptoms of diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
Highly functionalized 7-azaindoles as selective PPARγ modulators
Debenham, Sheryl D.,Chan, Audrey,Lau, Fiona WaiYu,Liu, Weiguo,Wood, Harold B.,Lemme, Karen,Colwell, Lawrence,Habulihaz, Bahanu,Akiyama, Taro E.,Einstein, Monica,Doebber, Thomas W.,Sharma, Neelam,Wang, Chaunlin F.,Wu, Margaret,Berger, Joel P.,Meinke, Peter T.
supporting information; experimental part, p. 4798 - 4801 (2009/06/17)
A series of highly functionalized 3-aroyl and 3-phenoxy-2-methyl-7-azaindoles have been identified, which are potent selective PPARγ modulators (SPPARγMs). Addition of substituents at the 6-position of the 7-azaindoles improves in vitro potency and pharmacokinetics. 7-Azaindoles have significantly improved off-target profiles compared to the parent indole series.